ADCT vs EXPD · rev $70.8M vs P/E 26, rev $10.60B
ADC Therapeutics SA (ADCT) versus Expeditors International of Washington, Inc. (EXPD) — a side-by-side from cached financials, not a winner call.
ADC Therapeutics SA (ADCT) is a biotechnology company listed on NYSE.
Expeditors International of Washington, Inc. (EXPD) is a integrated freight & logistics company listed on NYSE.
Latest reported ADCT revenue for 2024-12-31 was $70.8M. Net income was -$157.8M. Revenue was up 1.8% from 2023-12-31 to 2024-12-31. ADCT currently screens at market cap $141.2M.
Latest reported EXPD revenue for 2024-12-31 was $10.60B. Net income was $811.6M. Revenue was up 14.0% from 2023-12-31 to 2024-12-31. EXPD currently screens at market cap $21.01B and trailing P/E 26.0.
ADCT currently screens at market cap $141.2M. EXPD currently screens at market cap $21.01B and trailing P/E 26.0.
Not investment advice. Open the ADCT and EXPD stock pages for the full models.
Not investment advice.